Fate Therapeutics Inc. (FATE)
NASDAQ · Healthcare
Fate Therapeutics Inc. Shareholder Equity 2011–2025
Fate Therapeutics Inc. annual shareholder equity history from 2012 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Fate Therapeutics Inc. shareholder equity as of December 31, 2025: 207.2M, a 35.00% decrease year-over-year.
- Fate Therapeutics Inc. shareholder equity for 2025 were 207.2M, a 35.00% decrease from 2024.
- Fate Therapeutics Inc. shareholder equity for 2024 were 318.7M, a 13.49% decrease from 2023.
- Fate Therapeutics Inc. shareholder equity for 2023 were 368.4M, a 23.87% decrease from 2022.
- Fate Therapeutics Inc. shareholder equity for 2022 were 483.9M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Fate Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $207 |
| 2024 | $319 |
| 2023 | $368 |
| 2022 | $484 |
| 2021 | $679 |
| 2020 | $384 |
| 2019 | $245 |
| 2018 | $160 |
| 2017 | $77 |
| 2016 | $73 |
| 2015 | $38 |
| 2013 | $51 |
| 2012 | $-53 |
Fate Therapeutics Inc. Shareholder Equity — FAQ
Fate Therapeutics Inc. (FATE) shareholder equity over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see FATE's shareholder equity history?
The chart and table above show Fate Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.